Marketing-authorisation holder · Spain
B Braun Medical S.A.
86 medicines in 2 countries, as authorisation holder, manufacturer and marketer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Spain
86 medicines in 2 countries, as authorisation holder, manufacturer and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 86
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETATO DE POTASIO B.BRAUN 1 mEq/ml CONCENTRADO PARA SOLUCION PARA PERFUSION980 mg · Concentrado para solución para perfusión | Potassium | Spain | Marketed | 2001 |
| ADRENALINA B. BRAUN 1 mg/ml SOLUCION INYECTABLE1,8 mg · Solución inyectable | Epinefrina bitartrato | Spain | Marketed | 2007 |
| AGUA PARA PREPARACIONES INYECTABLES B.BRAUN DISOLVENTE PARA USO PARENTERAL1 ml · Disolvente para uso parenteral | Agua para preparaciones inyectables | Spain | Marketed | 1990 |
| AMICACINA B BRAUN 10 mg/ml SOLUCION PARA PERFUSION INTRAVENOSA1000 mg · Solución para perfusión | Amikacin | Spain | Marketed | 2001 |
| AMICACINA B BRAUN 5 MG/ML SOLUCION PARA PERFUSION INTRAVENOSA500 mg · Solución para perfusión | Amikacin | Spain | Marketed | 2001 |
| AMICACINA BRAUN 500 MG/2ML SOLUCIÓN INYECTABLE500 mg · Solución inyectable | Amikacin | Spain | Marketed | 1989 |
| AMINOPLASMAL HEPA SOLUCION PARA PERFUSION0,55 mg/ml + 0,86 mg/ml + 2,50 mg/ml + 8,80 mg/ml + 8,30 mg/ml + 10,60 mg/ml + 10,60 mg/ml + 0,80 mg/ml + 7,10 mg/ml + 1,66 mg/ml + 1,60 mg/ml + 1,50 mg/ml + 5,70 mg/ml + 6,30 mg/ml + 4,70 mg/ml + 8,80 mg/ml + 13,60 mg/ml + 4,60 mg/ml + 1,20 mg/ml + 3,70 mg/ml · Solución para perfusión | Asparagina, Acetiltirosina, Aspartic acid, Arginine, Alanine, Valine, Lysine, Acetylcysteine, Proline, Ornitina, Phenylalanine, Tryptophan, Glutamic acid, Glycine, Histidine, Isoleucine, Amino acids, Threonine, Methionine, Serine | Spain | Marketed | 1996 |
| AMINOPLASMAL PO 12,5% SOLUCION PARA PERFUSION525 mg + 250 mg + 1125 mg + 875 mg + 675 mg + 600 mg + 1050 mg + 600 mg + 250 mg + 288 mg + 875 mg + 100 mg + 1304 mg + 800 mg + 1550 mg + 1075 mg + 113 mg + 308 mg + 128 mg + 400 mg · Solución para perfusión | Phenylalanine, Tryptophan, Glutamic acid, Glycine, Histidine, Isoleucine, Amino acids, Threonine, Methionine, Ornitina, Proline, Acetylcysteine, Lysine, Valine, Alanine, Arginine, Aspartic acid, Acetiltirosina, Asparagina, Serine | Spain | Marketed | 1994 |
| AMPRES 10 MG/ML SOLUCION INYECTABLE50 ml · Solución inyectable | Chloroprocaine | Spain | Marketed | 2014 |
| ARGENPAL 42,5 mg BARRA CUTANEA50 mg · Barra cutánea | Plata | Spain | Marketed | 1951 |
| ATROPINA B. BRAUN 1 mg/ml SOLUCION INYECTABLE1 mg · Solución inyectable | Atropine | Spain | Marketed | 1957 |
| BUPIVACAINA B. BRAUN 5 mg/ml SOLUCION INYECTABLE50 mg · Solución inyectable | Bupivacaine | Spain | Marketed | 1999 |
| BUPIVACAINA B. BRAUN 7,5 mg/ml SOLUCION INYECTABLE75 mg · Solución inyectable | Bupivacaine | Spain | Marketed | 1999 |
| BUPIVACAINA HIPERBARICA B. BRAUN 5 mg / ml SOLUCION INYECTABLE5 mg · Solución inyectable | Bupivacaine | Spain | Marketed | 1997 |
| BUPIVACAINA HIPERBARICA B. BRAUN 5 mg / ml SOLUCION INYECTABLE EN MINI-PLASCO5 mg · Solución inyectable | Bupivacaine | Spain | Marketed | 2002 |
| CARDI-BRAUN MANTENIMIENTO SOLUCION PARA PERFUSION1,584 mg + 8,756 mg + 0,1976 mg + 0,1512 mg + 1,796 mg + 9,86 mg + 34,66 mg · Solución para perfusión | Citrato sodio, Trometamol, Citric acid, Dihidrogenofosfato, Potassium, Cloreto, Glucose | Spain | Marketed | 2008 |
| CARDI-BRAUN REPERFUSION SOLUCION PARA PERFUSION8,562 mg + 6,1963 mg + 0,773 mg + 0,5913 mg + 2,3419 mg + 40,553 mg + 8,799 mg + 7,897 mg · Solución para perfusión | Trometamol, Citrato sodio, Citric acid, Dihidrogenofosfato, Potassium, Glucose, Glutamic acid, Aspartic acid | Spain | Marketed | 2008 |
| CLORURO DE CALCIO BRAUN 100 mg/ml SOLUCION INYECTABLE10 g · Solución inyectable | Calcium chloride | Spain | Marketed | 1940 |
| CLORURO DE POTASIO BRAUN 1 mEq/ml CONCENTRADO PARA SOLUCION PARA PERFUSION7,45 mg · Solución para perfusión | Potassium | Spain | Marketed | 1994 |
| CLORURO DE POTASIO BRAUN 2 mEq/ml CONCENTRADO PARA SOLUCION PARA PERFUSION14,9 g · Concentrado para solución para perfusión | Potassium | Spain | Marketed | 1994 |
| CLORURO DE SODIO B. BRAUN 20% CONCENTRADO PARA SOLUCION PARA PERFUSION2 g · Solución para perfusión | Cloreto | Spain | Marketed | 1999 |
| ESCOPOLAMINA B. BRAUN 0,5 mg/ml SOLUCIÓN INYECTABLE0,5 mg · Solución inyectable | Escopolamina | Spain | Marketed | 2002 |
| ESTEROFUNDINA CON GLUCOSA 5% SOLUCION PARA PERFUSION0,5552 g + 0,0298 g + 0,0203 g + 0,0368 g + 0,5043 g + 5,5 g · Solución para perfusión | Cloreto, Potassium, Magnesio cloruro hexahidrato, Calcio cloruro dihidrato, Lactato sodio, Glucose | Spain | Marketed | 1965 |
| FISIOLOGICO B. BRAUN 0,9% SOLUCION PARA PERFUSION900 mg · Solución para perfusión | Cloreto | Spain | Marketed | 1963 |
| GENTAMICINA BRAUN 3 MG/ML SOLUCION PARA PERFUSION300 mg · Solución para perfusión | Gentamicin | Spain | Marketed | 2001 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 85 | 74 | 11 | CompaniesAll medicines |
| Saudi Arabia | 1 | 1 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.